Researcher.Life Logo

Neuropsychiatric Disease and Treatment : Impact Factor & More

eISSN: 1178-2021pISSN: 1176-6328
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Biological Psychiatry
SNIP
1.09
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Neuropsychiatric Disease and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuropsychiatric Disease and Treatment

Cistanche deserticola Stem Extract Attenuates Depression Through NF-\u03baB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation
  • 13 May 2026
  • Neuropsychiatric Disease and Treatment
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Na\xefve First-Episode Schizophrenia
  • 13 May 2026
  • Neuropsychiatric Disease and Treatment
Functional Impairment and Post-Stroke Depression: Potential Roles of Sleep Quality and Fatigue in a Cross-Sectional Structural Equation Analysis
  • 12 May 2026
  • Neuropsychiatric Disease and Treatment
Psychomotor Rehabilitation for Pediatric Delirium: A Study Protocol for a Randomized Controlled Trial Investigating Efficacy and Brain Electrophysiological Mechanisms
  • 11 May 2026
  • Neuropsychiatric Disease and Treatment
Role of Electroencephalographic Biomarkers as Predictors of Post-Stroke Cognitive Outcomes in Patients with Cerebral Infarction: Literature Review
  • 11 May 2026
  • Neuropsychiatric Disease and Treatment
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
  • 8 May 2026
  • Neuropsychiatric Disease and Treatment
Cistanche deserticola Stem Extract Attenuates Depression Through NF-\u03baB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation
  • 13 May 2026
  • Neuropsychiatric Disease and Treatment
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Na\xefve First-Episode Schizophrenia
  • 13 May 2026
  • Neuropsychiatric Disease and Treatment
Functional Impairment and Post-Stroke Depression: Potential Roles of Sleep Quality and Fatigue in a Cross-Sectional Structural Equation Analysis
  • 12 May 2026
  • Neuropsychiatric Disease and Treatment
Psychomotor Rehabilitation for Pediatric Delirium: A Study Protocol for a Randomized Controlled Trial Investigating Efficacy and Brain Electrophysiological Mechanisms
  • 11 May 2026
  • Neuropsychiatric Disease and Treatment
Role of Electroencephalographic Biomarkers as Predictors of Post-Stroke Cognitive Outcomes in Patients with Cerebral Infarction: Literature Review
  • 11 May 2026
  • Neuropsychiatric Disease and Treatment
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
  • 8 May 2026
  • Neuropsychiatric Disease and Treatment

FAQs on Neuropsychiatric Disease and Treatment